Lichenoid Keratosis: Diagnosis, Treatment, And Outcomes

Lichenoid keratosis, also known as lichen planus-like keratosis, benign lichenoid keratosis, solitary lichen planus, or involuting lichenoid plaque, is a common benign cutaneous lesion characterized by a small, inflamed macule or thin pigmented plaque exhibiting a lichenoid tissue reaction on histological examination.

What is lichenoid keratosis?

Lichenoid keratosis (LK) represents an inflammatory reaction pattern targeting pre-existing epidermal lesions, most frequently solar lentigines or seborrheic keratoses. It manifests as a sharply demarcated, often solitary plaque measuring 3–10 mm in diameter, typically displaying a pink to red-brown hue with surface scaling, erosion, or Wickham striae reminiscent of lichen planus. Predominantly affecting middle-aged to older adults, particularly fair-skinned females, LK arises on sun-exposed sites such as the trunk, upper arms, and thighs, though eruptive variants with multiple lesions have been documented.

The hallmark histological feature is a band-like lymphocytic infiltrate at the dermoepidermal junction, accompanied by vacuolar degeneration and Civatte bodies, confirming the lichenoid inflammatory process. Clinically, lesions evoke pruritus, tenderness, or irritation, prompting patient concern due to their rapid evolution from a subtle precursor to an inflamed plaque, often raising suspicion for basal cell carcinoma or actinic keratosis.

Who gets lichenoid keratosis?

Lichenoid keratosis predominantly impacts individuals over 40 years, with peak incidence in the fifth to seventh decades. Women are affected more frequently than men, potentially linked to cumulative sun exposure patterns. Risk factors include chronic UV exposure, as lesions favor acral and truncal sun-damaged skin. Rare eruptive forms occur in younger patients or following triggers like medications, vaccinations, or trauma.

• Middle-aged and elderly adults (highest prevalence)
• Fair-skinned individuals
• Females > males
• Sun-exposed body sites: chest, upper back, arms

Clinical features

Lesions present abruptly as solitary, well-circumscribed plaques evolving from innocuous solar lentigines into inflamed, scaly patches. Key characteristics include:

• Size: 3–15 mm diameter
• Color: Pink-red to violaceous-brown; may mimic melanoma in darker variants
• Surface: Fine scale, crusting, or erosion; occasionally warty
• Symptoms: Pruritus (most common), stinging, tenderness
• Distribution: Trunk (chest/presternal), extremities; rare on face or mucosa

Eruptive lichenoid keratoses feature multiple (5–50) lesions, often post-sunburn or drug exposure. Dermoscopically, LK displays light-brown pseudonetwork, gray dots/circles, shiny white streaks, and comedo-like openings, aiding differentiation from seborrheic keratosis or melanoma.

Diagnosis

Diagnosis hinges on clinicopathological correlation. Dermoscopy reveals organized patterns: structureless pink-white areas, white circles, serpentine vessels, and fading scalloped borders, supporting LK over malignancy.

Biopsy is indicated for atypical presentations, confirming lichenoid interface dermatitis with preserved architecture. Differential diagnoses include:

Follow-up dermoscopy monitors spontaneous regression, avoiding unnecessary intervention.

Pathophysiology and causes

The precise etiology remains elusive, but LK embodies an immune-mediated involution of senescent epidermal proliferations like solar lentigines or irritated seborrheic keratoses. Triggers encompass:

• UV radiation
• Frictional trauma
• Medications (NSAIDs, antihypertensives)
• Vaccinations (influenza)
• Hepatitis C infection

A cell-mediated hypersensitivity reaction elicits CD8+ T-lymphocyte infiltration, targeting dysplastic keratinocytes via apoptotic pathways.

Treatment

Asymptomatic LK often regresses spontaneously within months, warranting observation. Symptomatic or cosmetic concerns prompt intervention:

Topical imiquimod induces regression via immune stimulation, ideal for facial or recurrent lesions. Cryotherapy suits shallow plaques, minimizing scarring.

Outcome

Prognosis is excellent; most lesions involute without scarring. Recurrence is rare post-excision, though eruptive forms may persist. Regular skin surveillance is advised in sun-damaged patients.

Frequently Asked Questions (FAQs)

Q: Is lichenoid keratosis cancerous?

A: No, lichenoid keratosis is entirely benign, representing an inflammatory response rather than neoplasia. Biopsy excludes malignancy.

Q: Does lichenoid keratosis go away on its own?

A: Yes, many resolve spontaneously within 3–12 months; observation suffices for asymptomatic cases.

Q: What does lichenoid keratosis look like?

A: A small (5–10 mm), red-brown, scaly, itchy plaque on sun-exposed skin, often solitary on the chest or arms.

Q: How is lichenoid keratosis treated?

A: Options include topical steroids for symptoms, cryotherapy or curettage for removal, and observation for self-resolution.

Q: Can lichenoid keratosis be prevented?

A: Sun protection (SPF 50+ daily) reduces risk by minimizing precursor lentigines.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb